Poseida Therapeutics
About:
Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.
Website: http://poseida.com
Twitter/X: PoseidaThera
Top Investors: Novartis, Fidelity, Perceptive Advisors, Schonfeld Strategic Advisors, Longitude Capital
Description:
Poseida Therapeutics is a clinical-stage biopharmaceutical company utilizing genome engineering capabilities to develop targeted therapeutics for patients with high unmet medical needs. The company develops a pipeline of autologous and allogeneic chimeric antigen receptor T cell or CAR-T, product candidates focusing on the treatment of hematological malignancies and solid tumors.
$460M
$50M to $100M
San Diego, California, United States
2014-01-01
info(AT)poseida.com
Eric Ostertag
251-500
2023-08-07
Public
© 2025 bioDAO.ai